免疫治疗

B组143例，单纯接受主动免疫治疗；

143 cases in group B , only with active immunotherapy ;

近年来，以DC为基础的肿瘤疫苗已成为肿瘤免疫治疗的热点。

Recently , DC based vaccine has been a hotpoint in tumor immunotherapy .

B细胞非霍奇金淋巴瘤的放射免疫治疗

Radioimmunotherapy of B cell non - Hodgkin 's lymphoma

DNA疫苗与肿瘤免疫治疗

DNA vaccines and cancer immunotherapy

这为进一步研究人LIGHT的功能及探索肿瘤的免疫治疗新方法奠定了一定的实验基础。

These results have provided a good foundation for the further functional research of LIGHT and exploring new methods of tumor immunotherapy .

结论DC瘤苗以其安全、有效、易行的特点，将会在肿瘤免疫治疗中具有良好的应用前景。

Conclusion DC vaccine is promising in tumor immunotherapy owing to its safety , efficiency and convenience .

IL-2基因修饰的树突状细胞免疫治疗肝癌的实验研究

Study of Immunotherapy on HCC with IL-2 Engineered Human Dendritic Cells

Zevalin~（TM）：一种放射免疫治疗新药

Zevalin ~ ( TM ): A new radioimmunotherapy agent

因此，如何提高DC的功能，避免肿瘤逃逸的发生，是当今肿瘤免疫治疗的研究热点之一。

Thus , the study on immune therapy is focused on enhancing functional activity of DC and breaking tumor escape mechanisms .

Toll样受体：免疫治疗的新靶位

Toll-like receptors : a new immune therapeutic target

激发型CD40单克隆抗体联合特异性细胞毒T淋巴细胞对B细胞淋巴瘤的免疫治疗作用

Therapeutic effect of agonistic CD40 monoclonal antibody combined with CTL on hu-SCID mouse B lymphoma model

目的：研究免疫治疗用于治疗及预防骨髓移植（bonemarrowtransplantation，BMT）后的白血病复发。

Objective : To study immunotherapy for leukemia relapse and prophylaxis after bone marrow transplantation ( BMT ) .

乙肝病毒前S/S抗原的重组表达质粒对HBV转基因小鼠的免疫治疗效应

Immune therapeutical effect induced by inoculation with recombinant plasmid encoding preS / S antigen in HBV DNA transgenic mice

Poly（I：C）在肿瘤免疫治疗中的作用已被广泛论证。

The effect of poly ( I : C ) in tumor immune therapy have been well demonstrated .

树突状细胞（DC）是专职的抗原递呈细胞（APC），是唯一能激活纯真T细胞的APC，在肿瘤免疫治疗中起重要作用。

Dendritic cells ( DCs ) are a specialized system of antigen - presenting cells .

CD4~+CD（25）~+调节性T细胞在肿瘤免疫治疗中的价值及应用前景

The Prospects of the usage of CD_4 ~ + CD_ ( 25 ) ~ + regulatory T cells in cancer immunotherapy

因而临床上一般用NK细胞免疫治疗联合化疗来达到治疗肿瘤更好的效果。

In clinical , NK cells are used in combination with chemotherapy to treat tumors .

抗腺癌肿瘤疫苗对小鼠Lewis肺癌的主动特异性免疫治疗

Active specific immunotherapy of a murine metastatic Lewis tumor using a cancer vaccine against adenocarcinoma

目的探讨树突状细胞（DC）-细胞因子诱导的杀伤细胞（CIK）细胞免疫治疗恶性肿瘤的疗效及机制。

Objective To assess the therapeutic efficacy and the mechanism of DC-CIK immunotherapy against malignant tumors .

T和NK细胞比值显著下降可能预示患者病情严重，T和NK细胞ζ链水平正常的肿瘤患者可能是免疫治疗的适应证。

The patients with normal T and NK ζ chain level may be indicated for immunotherapy .

GM-CSF基因免疫治疗小鼠骨髓瘤的实验研究

Experimental study on antitumor effects of GM-CSF gene immunization on mouse myeloma

低剂量辐射激活NK杀伤活性在过继免疫治疗中的研究进展

Progress of research on activation function of NK cell exposed to low dose radiation in adoptive cellular immunotherapy

近年来随着人们了解的深入，基于DC的肿瘤免疫治疗方法越来越受关注。

With the intensive understanding to the biological behaviors of DC , people pay more and more attention to the role of DC in cancer immune therapy .

结论Kras癌基因的成功克隆及逆转录病毒表达载体的构建，为胰腺癌的免疫治疗研究奠定了基础。

Conclusion The successful clone of K-ras oncogene and construction of retroviral vector lays the foundation for the immunotherapy of pancreatic cancer .

Mage-A3抗原肽负载DC过继免疫治疗乳腺癌的实验研究

Immunotherapy of dendritic cells loaded with the peptide derived from mage-a_3 on mice breast cancer

CIK细胞过继性免疫治疗的护理

Nursing to the CIK Cell Adoptive Immunotherapy Q & A on Sex

目的研究MAGE3抗原肽对肝细胞癌（HCC）患者进行免疫治疗的可行性。

Objective To explore the possibility of immune therapy for hepatocellular carcinoma ( HCC ) with MAGE-3 antigen peptide ( FLWGPRALV ) .

K-ras突变多肽诱导胰腺癌免疫治疗的实验研究

In Vivo Research of Immunotherapy on Pancreatic Cancer Induced by K-ras Mutated Peptide

红细胞TF抗原用于老年恶性肿瘤病人的特异性主动免疫治疗

Using erythrocyte Thomsen Fridenreich ( TF ) antigen to achieve active specific immunotherapy on elderly cancer patients

以上研究结果显示出丝裂霉素灭活FB卜3一GM一csF后作为瘤苗的有效性和白血病免疫治疗的可行性。

The above results showed efficiency of vaccination with mitomycin-C inactivated FBL-3-GM-CSF into mice and feasibility of immune therapy of leukemia .